GGrantIndex
Sort

51,593 grants matching hepatitis

IHBEM: Modeling the influence of individual and network behavior on HIV/HCV transmission dynamics

$749,953
Sunil S Solomon · Johns Hopkins University · · FY2023 · MPS

Biliary Atresia Consortium: Data Coordinating Center

$749,909
University Of Michigan At Ann Arbor · U01 · FY2002 · DK

HIV and Hepatocellular Carcinoma in Uganda: The H2U Consortium

$749,900
Gregory D Kirk · Johns Hopkins University · U54 · FY2016 · CA

HIV and Hepatocellular Carcinoma in Uganda: The H2U Consortium

$749,900
Gregory D Kirk · Johns Hopkins University · U54 · FY2015 · CA

HIV and Hepatocellular Carcinoma in Uganda: The H2U Consortium

$749,899
Gregory D Kirk · Johns Hopkins University · U54 · FY2014 · CA

A NOVEL STRATEGY TO INHIBIT SARS-COV-2 INFECTION AND COVID-19

$749,787
Philippe Andre Gallay · Scripps Research Institute, The · R01 · FY2025 · AI

Novel Drug Carrier System for the Treatment of Alcoholic Liver Disease

$749,725
Philip Bauer · Endoprotech, Inc. · R44 · FY2016 · AA

International epidemiology Databases to Evaluate AIDS (IeDEA) Southern Africa.

$749,723
Eliane Rohner · Universitat Bern · U01 · FY2025 · AI

Indiana University Center for Pediatric Pharmacology and Precision Medicine

$749,663
Jamie L Renbarger · Indiana University Indianapolis · U54 · FY2017 · HD

SYRINGE ACCESS AND HIV RISK

$749,612
Hispanic Health Council · R01 · FY2001 · DA

Molecular Mechanisms of TGF-beta Signaling Pathway

$749,459
Ying Zhang · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA

Lipid-Mediated Control of Acetyl-CoA Metabolism in the Pathogenesis of NAFLD

$749,458
David E Cohen · Brigham And Women'S Hospital · R01 · FY2024 · DK

Engineering Multicellular Tissue Structure, Function, and Vascularization

$749,421
Christopher S Chen · Boston University (Charles River Campus) · R01 · FY2016 · EB

Role Of Monocytes In AIDS And As Targets For Antiviral Therapy

$749,298
Sharon M Wahl · National Institute Of Dental & Craniofacial Research · ZIA · FY2011 · DE

The Progression of Hepatitis C Among IDUs with HIV

$749,282
David L Thomas · Johns Hopkins University · R01 · FY2012 · DA

HUMAN REQUIREMENTS FOR THE NUTRIENT CHOLINE

$749,274
University Of North Carolina Chapel Hill · R01 · FY2004 · DK

Xenobiotic metabolism, cancer chemoprevention and cancer biomarkers

$749,248
Frank J Gonzalez · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

IeDEA West Africa Renewal 3

$749,211
Francois Dabis · Adera · U01 · FY2017 · AI

Assessing Diabetes Risk Origins in Teens (ADROIT)

$749,173
Lorraine E Katz · Children'S Hosp Of Philadelphia · U01 · FY2025 · DK

IeDEA West Africa Renewal 3

$748,992
Francois Dabis · Adera · U01 · FY2018 · AI

Synergy of Hydroxyurea and Erythropoietin on Fetal Hemoglobin in SCD

$748,968
Mark Thomas Gladwin · Heart, Lung, And Blood Institute · Z01 · FY2007 · HL

Rhesus HHV-8 homologue in AIDS-related malignancies

$748,902
Scott W Wong · Oregon Health & Science University · R01 · FY2016 · CA

Improving Hepatitis C Treatment in Injection Drug Users

$748,895
Steven L Batki · Upstate Medical University · R01 · FY2006 · DA

Development and Validation of Novel NSG Mouse Models for Human Stem Cell Therapy

$748,845
Dale L Greiner · Univ Of Massachusetts Med Sch Worcester · R24 · FY2015 · OD

Effects of GLP-l receptor agonists on cardiometabolic alterations in HIV-associated lipohypertrophy

$748,650
Grace A McComsey · Case Western Reserve University · R01 · FY2023 · DK